Rockefeller scientists engineer next-generation antibody to replace IVIG therapy

Post author:admin
Post published:November 7, 2025
Post category:uncategorized

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Study finds no increased risk from vaccine aluminum exposure

Normothermic regional perfusion could increase the number of patients receiving lung transplants

Chronic kidney disease accelerates cognitive decline through heart-brain pathways

Helpful Links

Subscribe To Us